Disclosures for "Effects of a four-strain probiotic on inflammatory markers in Parkinson's disease: a multicentre randomised controlled trial (the SymPD study)"
-
The institution of Valentina Leta has received research support from Parkinson's UK. The institution of Valentina Leta has received research support from NIHR BRC. The institution of Valentina Leta has received research support from Symprove ltd. Valentina Leta has received personal compensation in the range of $500-$4,999 for serving as a Speaker, and member of advisory board with Bial. Valentina Leta has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Merz. Valentina Leta has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Abbvie. Valentina Leta has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Britannia.
-
Miss Mandal has nothing to disclose.
-
Mr. Zinzalias has nothing to disclose.
-
Ms. Staunton has nothing to disclose.
-
Dr. Batzu has nothing to disclose.
-
The institution of Dhaval Trivedi has received research support from Symprove ltd .
-
Dr. Rosqvist has nothing to disclose.
-
Dr. Timpka has received personal compensation in the range of $0-$499 for serving as a Consultant for TransPerfect. The institution of Dr. Timpka has received research support from Swedish Parkinson Foundation. Dr. Timpka has received personal compensation in the range of $0-$499 for serving as a Expert with Swedish National Board of Health and Welfare.
-
Mrs. Van Vliet has nothing to disclose.
-
Miss Podlewska has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bial . The institution of Miss Podlewska has received research support from Wellcome Trust.
-
Ms. Parry has nothing to disclose.
-
-
An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GKC. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cynapsus. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lobsor. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stada. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Profile Pharma. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Synovion. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scion. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. An immediate family member of Mrs. Rizos has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Parkinson's Journal. The institution of an immediate family member of Mrs. Rizos has received research support from EU. The institution of an immediate family member of Mrs. Rizos has received research support from Parkinson's UK. The institution of an immediate family member of Mrs. Rizos has received research support from Parkinson's Foundation. The institution of an immediate family member of Mrs. Rizos has received research support from Wellcome trust. The institution of an immediate family member of Mrs. Rizos has received research support from MRC. An immediate family member of Mrs. Rizos has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Mrs. Rizos has received publishing royalties from a publication relating to health care. An immediate family member of Mrs. Rizos has received publishing royalties from a publication relating to health care.
-
Dr. Chung-Faye has nothing to disclose.
-
Per Odin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Per Odin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Per Odin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lobsor. Per Odin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Per Odin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia. Per Odin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Per Odin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nordic Infucare. Per Odin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon. Per Odin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. The institution of Per Odin has received research support from AbbVie. The institution of Per Odin has received research support from Parkinsonfonden. The institution of Per Odin has received research support from Swedish Research Council. The institution of Per Odin has received research support from Region Skåne. Per Odin has received publishing royalties from a publication relating to health care.
-
Prof. Pariante has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for 2021 Lundbeck (Italia) conference inflammation 1,500 euros 2021 Lundbeck (Italia) conference inflammation 2,000 euros . The institution of Prof. Pariante has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Editor Brain Behavior and Immunity (BBI), BBI Health and BBI Integrative. The institution of Prof. Pariante has received research support from 2022 Compass trial on PTSD £89,020.
-
Dr. Borsini has nothing to disclose.
-
Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acadia, GSK, Scion, Britannia , Lobsor. Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Britannia, Scion, Sunovion, UCB, . Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Britannia, UCB, Zambon. Dr. Chaudhuri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NPJ PD journal. The institution of Dr. Chaudhuri has received research support from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.